Peptidomimetics in cancer targeting
Abstract The low efficiency of treatment strategies is one of the main obstacles to developing cancer inhibitors. Up to now, various classes of therapeutics have been developed to inhibit cancer progression. Peptides due to their small size and easy production compared to proteins are highly regarde...
Saved in:
Main Authors: | Mohammad Mahmoudi Gomari (Author), Shadi Abkhiz (Author), Taha Ghantab Pour (Author), Ehsan Lotfi (Author), Neda Rostami (Author), Fatemeh Nafe Monfared (Author), Babak Ghobari (Author), Mona Mosavi (Author), Behruz Alipour (Author), Nikolay V. Dokholyan (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short Cationic Peptidomimetic Antimicrobials
by: Rajesh Kuppusamy, et al.
Published: (2019) -
Structure Based Antibody-Like Peptidomimetics
by: Mark I. Greene, et al.
Published: (2012) -
Peptides and Peptidomimetics for Antimicrobial Drug Design
by: Biljana Mojsoska, et al.
Published: (2015) -
Heterocycles in Peptidomimetics and Pseudopeptides: Design and Synthesis
by: Ambra Guarnaccio, et al.
Published: (2012) -
Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm
by: Rajesh Kuppusamy, et al.
Published: (2023)